What is Bextra? (FDA Recalled Drug)
Bextra, also known as valdecoxib, is a prescribed medication used to alleviate the problems associated with arthritis and other inflammation-related conditions. The drug helps reduce the pain of swelling and fever without causing stomach irritation like aspirin.
NSAIDs work by blocking a chemical in the body called cycloxgenase. Cylooxgenase-1, or COX-1, shields the stomach from the harsh hydrochloric acid it contains, while COX-2, is found in inflamed tissues and causes the pain of fever, infection and arthritis. The drugs were effective for alleviating this pain, but the relief benefits were limited because the traditional NSAIDs caused stomach irritation. Taking an NSAIDs like aspirin causes pain because it blocks both chemicals (relieving pain) but also disabling the stomach protection of COX-1.
When the development of aspirin and ibuprofen came along, medical science searched for a way to provide a safe, non-addictive pain and fever relief without the risk of serious gastrointestinal damage. This came in the late 1990's when scientists isolated the protein COX-2 from COX-1 and created drugs to selectively block COX-2 without interfering with COX-1.
When these COX-2 inhibitors like Bextra were introduced, they relieved the pain of inflammation like arthritis without causing significant stomach damage. They soon became biggest selling pain relievers in the world, with sales in the tens of billions of dollars. Unfortunately, clinical trials began to warn patients about potential risks of increased cardiovascular trauma due to the disruption by COX-2 drugs of the way that the kidneys regulate blood pressure after filtering out impurities. These drugs started causing blood clots to form in the arteries causing heart attacks and strokes. Despite the documented accounts of these risks, doctors continued to prescribe Bextra in larger quantities.
Bextra is dangerous because it increases the patient's chance for heart attacks and strokes as well as endangering patients undergoing post-operative recovery for heart surgery. Patients taking Bextra also face an increased risk of developing potentially fatal skin allergies called Steven-Johnson syndrome and Toxic Epidermal Necrolysis Syndrome. After further review, the FDA re-evaluated the drug and asked Pfizer to remove the drug from the market on April 7th, 2005.
Unfortunately the damage has already been done. Bextra caused millions of people to live in fear, anxiety and illness because the were prescribed an unsafe drug. If you've suffered from these dangerous and potentially fatal side effects, you have the right to seek compensation for your physical and emotional anguish. Immediately consult your physician to assess any damage to your health and immediately contact an experienced lawyer to help you get the answers and compensation you deserve. You are entitled to help. Contact a Bextra lawyer today!
For more information about Bextra, please visit our website at http://www.resource4bextrainfo.com
This article may be freely reprinted as long as this resource box is included and all hyperlinks remain intact.
Latest News
BioImagene CEO, Dr. Ajit Singh, Speaks On Enabling Personalized ... MarketWatch - Digital pathology, a key enabler for personalized medicine, will aid clinicians in managing and interpreting data from a whole new set of diagnostic tests ... Aperio Introduces SecondSlide(TM) Digital Slide Sharing Network |
Boston Globe | Medicine for the Job Market New York Times, United States - By JONATHAN GRUBER A CENTRAL feature of Barack Obama’s presidential campaign was an aggressive plan to expand health insurance coverage by subsidizing ... New Report Shows Slower Premium Growth, But Increasing Pressure to ... Health Corps Research database from the US Library of Medicine |
SmartAboutHealth | American College of Surgeons Comments on Institute of Medicine ... MarketWatch - CHICAGO, Dec 03, 2008 /PRNewswire-USNewswire via COMTEX/ -- The American College of Surgeons (ACS) today recognized the Institute of Medicine (IOM) for its ... BMC Internal Medicine Residency Program Achieves National ... Report urges more sleep for medical residents Medical Residents Must Sleep After 16 Hours, Experts Urge |
Research and Markets: 2008 Integrative Medicine and Dietary ... MarketWatch - In this 32-page issue, we offer a breakdown of 2007 US Complementary and Alternative Medicine sales data and provides a detailed analysis of new integrative ... |
![]() Javno.hr | 34 Nigerian Children Dead From Tainted Medicine Voice of America - By VOA News Nigerian health officials say they are flying in doses of an antidote for a poisoned teething medicine that has now killed 34 infants. ... 'Toxic' syrup kills Nigerian babies Teething mixture kills more Nigerian babies Nigeria infant drug toll hits 34, antidote flown in |
Research database from the US Library of Medicine The Plain Dealer - cleveland.com, OH - Search PubMed, Clinicaltrials.gov, the CDC and a dozen other medical sites - all at once. AP MEDICAL VIDEO by Michael O'Malley and Joan Mazzolini/Plain ... |
A New Index of Preventive Medicine Companies Motley Fool - The accompanying table [click to enlarge] presents statistics and the top 15 rated companies in the ETF Innovators [ETFI] Preventive Medicine Index. ... |
American Academy of Dermatology Issues Position Statement on Vitamin D MarketWatch - The currently recommended adequate intake levels established by the Institute of Medicine may be revised upward due to evolving research on the increasing ... |
NIGERIA: Jos displaced grapple with food, water, medicine shortages IRINnews.org, NY - JOS, 4 December 2008 (IRIN) - Water, medicine and food supplies are running low for an estimated 10000 people displaced by violence in Jos, northern Nigeria ... |
![]() Discover Magazine | "Rogue" stem cell clinics exploit hope: report Reuters - "The direct-to-consumer portrayal of stem cell medicine is optimistic and unsupported by published evidence," Timothy Caulfield of the University of Alberta ... Scientists warn of “rogue” online stem cell clinics Internet stem-cell clinics 'exploiting' MS and Parkinson's patients The International Society for Stem Cell Research Releases New ... |
Resources
-
Sorry Currently Unavailable

